Home/Filings/4/0000950170-24-064713
4//SEC Filing

AFEYAN NOUBAR 4

Accession 0000950170-24-064713

CIK 0001822462other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 5:05 PM ET

Size

15.0 KB

Accession

0000950170-24-064713

Insider Transaction Report

Form 4
Period: 2024-05-22
Flagship Pioneering, LLC
Director10% Owner
Transactions
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,914$9,999,9951,814,914 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)
    Exercise: $0.00Common Stock (1,814,914 underlying)
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,915$10,000,0001,814,915 total(indirect: By Flagship Pioneering Fund VII, L.P.)
    Exercise: $0.00Common Stock (1,814,915 underlying)
Transactions
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,914$9,999,9951,814,914 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)
    Exercise: $0.00Common Stock (1,814,914 underlying)
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,915$10,000,0001,814,915 total(indirect: By Flagship Pioneering Fund VII, L.P.)
    Exercise: $0.00Common Stock (1,814,915 underlying)
Transactions
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,914$9,999,9951,814,914 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)
    Exercise: $0.00Common Stock (1,814,914 underlying)
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,915$10,000,0001,814,915 total(indirect: By Flagship Pioneering Fund VII, L.P.)
    Exercise: $0.00Common Stock (1,814,915 underlying)
AFEYAN NOUBAR
Director10% Owner
Transactions
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,914$9,999,9951,814,914 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)
    Exercise: $0.00Common Stock (1,814,914 underlying)
  • Purchase

    Pre-Funded Warrants to purchase Common Stock

    2024-05-22$5.51/sh+1,814,915$10,000,0001,814,915 total(indirect: By Flagship Pioneering Fund VII, L.P.)
    Exercise: $0.00Common Stock (1,814,915 underlying)
Footnotes (3)
  • [F1]On May 22, 2024, pursuant to an underwritten public offering by the Issuer, Flagship Pioneering Special Opportunities Fund II, L.P. ("Flagship Opportunities Fund II") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") acquired pre-funded warrants (the "Pre-Funded Warrants") to purchase 1,814,914 and 1,814,915 shares of Common Stock, respectively, at a purchase price of $5.5099 per Pre-Funded Warrant. The Pre-Funded Warrants are immediately exercisable and do not have an expiration date; however, a holder of Pre-Funded Warrants may not exercise the Pre-Funded Warrant if the holder, together with its affiliates, would beneficially own more than 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise.
  • [F2]Securities held by Flagship Opportunities Fund II. Flagship Pioneering Special Opportunities Fund II General Partner LLC ("Flagship Opportunities Fund II GP") is the general partner of Flagship Opportunities Fund II. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Opportunities Fund II GP. Noubar B. Afeyan, Ph.D. is the CEO and sole stockholder of Flagship Pioneering. Each of the reporting persons except Flagship Opportunities Fund II disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
  • [F3]Securities held by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Fund VII GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Documents

1 file

Issuer

Foghorn Therapeutics Inc.

CIK 0001822462

Entity typeother

Related Parties

1
  • filerCIK 0001222012

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:05 PM ET
Size
15.0 KB